Cas 664323-83-5,N-[2-(dimethylamino)ethyl]-2-(4-hydroxy-1,1'-biphenyl-3-yl)-N-methyl-1,3-benzothiazole-6-carboxamide

664323-83-5

Post Buying Request

Basic information

Product Name: N-[2-(dimethylamino)ethyl]-2-(4-hydroxy-1,1'-biphenyl-3-yl)-N-methyl-1,3-benzothiazole-6-carboxamide
Synonyms: N-[2-(dimethylamino)ethyl]-2-(4-hydroxy-1,1'-biphenyl-3-yl)-N-methyl-1,3-benzothiazole-6-carboxamide
CAS NO:664323-83-5
Molecular Formula:
Molecular Weight: 431.558
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-[2-(dimethylamino)ethyl]-2-(4-hydroxy-1,1'-biphenyl-3-yl)-N-methyl-1,3-benzothiazole-6-carboxamide(CAS DataBase Reference)
NIST Chemistry Reference: N-[2-(dimethylamino)ethyl]-2-(4-hydroxy-1,1'-biphenyl-3-yl)-N-methyl-1,3-benzothiazole-6-carboxamide(664323-83-5)
EPA Substance Registry System: N-[2-(dimethylamino)ethyl]-2-(4-hydroxy-1,1'-biphenyl-3-yl)-N-methyl-1,3-benzothiazole-6-carboxamide(664323-83-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 664323-83-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

664323-83-5 Suppliers

Recommended suppliers

664323-83-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 664323-83-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,4,3,2 and 3 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 664323-83:
(8*6)+(7*6)+(6*4)+(5*3)+(4*2)+(3*3)+(2*8)+(1*3)=165
165 % 10 = 5
So 664323-83-5 is a valid CAS Registry Number.

664323-83-5Upstream product

664323-83-5Downstream Products

664323-83-5Relevant academic research and scientific papers

NOVEL USE OF BENZOTHIAZOLE DERIVATIVES

-

Page 30, (2008/06/13)

The use of compounds of formula (I) wherein X, A, B, D, R1 and R2 are as defined in the Specification and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment or prophylaxis of diseases or conditions in which inhibition of kinase Itk activity is beneficial is disclosed. Certain novel compounds of formula (I), together with processes for their preparation, compositions containing them and their use in therapy are also disclosed.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 664323-83-5